Basilea Pharmaceutica AG (LON:0QNA)
London flag London · Delayed Price · Currency is GBP · Price in CHF
45.73
+1.05 (2.35%)
Feb 21, 2025, 4:19 PM BST

Basilea Pharmaceutica AG Market Cap

Basilea Pharmaceutica AG has a market cap or net worth of 486.49 million as of February 21, 2025. Its market cap has increased by 33.83% in one year.

Market Cap
486.49M
Enterprise Value
478.54M
Revenue
183.82M
Ranking
n/a
PE Ratio
7.11
Stock Price
45.73

Market Cap Chart

Since March 25, 2004, Basilea Pharmaceutica AG's market cap has increased from 231.10M to 486.49M, an increase of 110.51%. That is a compound annual growth rate of 3.62%.

History

DateMarket Cap% Change
Feb 21, 2025486.49M10.17%
Dec 30, 2024441.59M12.00%
Dec 29, 2023394.28M-19.52%
Dec 30, 2022489.93M24.72%
Dec 30, 2021392.83M-17.81%
Dec 30, 2020477.95M20.82%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 30, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
AstraZeneca 181.54B
GSK plc 58.32B
Haleon 35.36B
Smith & Nephew 9.01B
Hikma Pharmaceuticals 5.12B
ConvaTec Group 5.06B
HUTCHMED (China) 2.19B
Genus 1.17B
Market Cap Rankings